Webinar: The Beginning of the End: Immunoprofiling Coming of Age

As immuno-oncology makes major inroads into the battle against cancer, the need for effective prognostic and predictive biomarkers is growing rapidly, as response rates continue in the 10 – 30% range and the menu of options grows at an accelerating pace.
Multiplex immunofluorescence is the most effective and efficient way to identify specific immune cell types and their location and state of activation in the tumor microenvironment, and to assess check-point expression, all at the same time. This is highly beneficial for exploring immune evasion mechanisms, finding potential biomarkers for assessing the mechanism of action and predicting response, and for potentially tracking response.

This webcast will provide an overview of multiplex immunofluorescence methods and then present results from a recent study demonstrating the prognostic power of assessing the composition and relationships of cells in the tumor microenvironment in-situ in FFPE tissue sections. Ultimately, this capability should accelerate the development of immuno-oncology agent combinations and improve outcomes for patients with cancer.


Dr. Bernie Fox
Chief of the Laboratory of Molecular and Tumor Immunology
Providence Portland Medical Center

Dr. Jayshan Carpen
Nature Research

In this webcast, you will:
  • Gain a clearer understanding of multiplex immunofluorescence and how to characterize cell-level immuno-biology in intact FFPE tissue sections
  • See experimental evidence of the real-world application of multiplexing and how it can be applied to study the tumor microenvironment.

Webinar On-Demand